{"id":670923,"date":"2026-01-11T20:16:05","date_gmt":"2026-01-11T20:16:05","guid":{"rendered":"https:\/\/microscopemedia.com\/?p=670923"},"modified":"2026-01-11T20:16:05","modified_gmt":"2026-01-11T20:16:05","slug":"cercetatorii-maghiari-au-pus-la-punct-un-medicament-anticancer-surprinzator-de-eficient-a-distrus-o-tumora-canceroasa-de-san-extrem-de-agresiva-de-la-prima-doza","status":"publish","type":"post","link":"https:\/\/microscopemedia.com\/?p=670923","title":{"rendered":"Cercet\u0103torii maghiari au pus la punct un medicament anticancer surprinz\u0103tor de eficient \/ A distrus o tumor\u0103 canceroas\u0103 de s\u00e2n extrem de agresiv\u0103 de la prima doz\u0103"},"content":{"rendered":"
<\/div>\n

O echip\u0103 de cercet\u0103tori maghiari a anun\u021bat progrese semnificative \u00een dezvoltarea unui medicament anticancer<\/a> experimental care ar putea oferi o abordare nou\u0103 \u00een tratarea unor forme de cancer dificil de tratat.<\/p>\n

Medicamentul, numit LiPyDau, se bazeaz\u0103 pe o versiune modificat\u0103 a unui compus folosit \u00een chimioterapie, care s-a dovedit de p\u00e2n\u0103 la 1.000 de ori mai puternic \u00een distrugerea celulelor tumorale dec\u00e2t medicamentele conven\u021bionale.<\/p>\n

Cum func\u021bioneaz\u0103<\/h2>\n

Problema ini\u021bial\u0103 cu acest compus foarte toxic a fost c\u0103, \u00een forma sa simpl\u0103, ar afecta \u0219i celulele s\u0103n\u0103toase, ceea ce l-ar face periculos pentru pacien\u021bi.<\/p>\n

Cercet\u0103torii au rezolvat aceast\u0103 provocare folosind o tehnologie special\u0103 de livrare a medicamentului: \u00eencapsularea \u00een particule liposomale \u2014 mici \u201ebule\u201d formate dintr-un material similar gr\u0103similor.<\/p>\n

Aceste particule protejeaz\u0103 \u021besutul s\u0103n\u0103tos \u0219i elibereaz\u0103 substan\u021ba activ\u0103 \u00een mod mai concentrat \u00een zona tumorii, unde vasele sanguine slabe permit medicamentului s\u0103 ias\u0103 din fluxul sanguin \u0219i s\u0103 ac\u021bioneze direct asupra celulelor canceroase.<\/p>\n

Rezultate promi\u021b\u0103toare la animale<\/h2>\n

Testele efectuate pe animale arat\u0103 rezultate surprinz\u0103tor de bune.<\/p>\n

Tumorile de s\u00e2n, piele \u0219i pl\u0103m\u00e2ni au \u00eencetat s\u0103 mai creasc\u0103 dup\u0103 tratament, iar la un cancer de s\u00e2n extrem de agresiv, tumora a disp\u0103rut complet \u0219i nu a revenit.<\/p>\n

Cercet\u0103torii subliniaz\u0103 c\u0103 unele rezultate au fost ob\u021binute dup\u0103 o singur\u0103 doz\u0103, ceea ce arat\u0103 eficacitate puternic\u0103 \u00een fazele ini\u021biale ale testelor.<\/p>\n

Ce urmeaz\u0103<\/h2>\n

De\u0219i rezultatele sunt promi\u021b\u0103toare, LiPyDau se afl\u0103 \u00een prezent \u00een faza de teste preclinice, adic\u0103 pe animale \u2014 \u00eenc\u0103 nu a \u00eenceput studiul pe oameni.<\/p>\n

Cercet\u0103torii sper\u0103 s\u0103 continue testele pe modele mai mari \u0219i apoi s\u0103 ob\u021bin\u0103 aprob\u0103rile necesare pentru studii clinice pe pacien\u021bi, ceea ce ar putea dura c\u00e2\u021biva ani.<\/p>\n

Dac\u0103 totul merge bine, acest medicament ar putea deveni unul dintre primele tratemente anticancer dezvoltate \u00een Ungaria \u0219i ar putea oferi op\u021biuni noi pentru pacien\u021bi cu tumori greu tratabile.<\/p>\n

Ce \u00eenseamn\u0103 pentru pacien\u021bi<\/h2>\n

Medicamentele conven\u021bionale de chimioterapie pot avea efecte secundare puternice \u0219i nu func\u021bioneaz\u0103 la toate tipurile de tumori.<\/p>\n

Noua abordare caut\u0103 s\u0103 maximizeze distrugerea celulelor canceroase f\u0103r\u0103 a afecta prea mult \u021besutul s\u0103n\u0103tos, ceea ce ar putea duce la tratamente mai eficiente \u0219i mai pu\u021bin toxice dec\u00e2t chimioterapia tradi\u021bional\u0103.<\/p>\n","protected":false},"excerpt":{"rendered":"

O echip\u0103 de cercet\u0103tori maghiari a anun\u021bat progrese semnificative \u00een dezvoltarea unui medicament anticancer experimental care ar putea oferi o abordare nou\u0103 \u00een tratarea unor forme de cancer dificil de … Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":670924,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/670923"}],"collection":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=670923"}],"version-history":[{"count":0,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/posts\/670923\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=\/wp\/v2\/media\/670924"}],"wp:attachment":[{"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=670923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=670923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microscopemedia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=670923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}